Page last updated: 2024-08-23

mifepristone and Local Neoplasm Recurrence

mifepristone has been researched along with Local Neoplasm Recurrence in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Abd Jamil, AH; Chung, I; Mat Adenan, NA; Omar, IS1
Cai, Y; Conzen, SD; Goyal, A; Hall, BA; Kocherginsky, M; Skor, MN; Wonder, EL1
Brady, WE; Hoffman, JS; Mannel, RS; Rocereto, TF; Rotmensch, J; Shahin, MS; Small, L1
Heikinheimo, O; Koivisto-Korander, R; Leminen, A1
Olson, JJ1
Eisenhauer, EA; Fisher, B; Norris, B; Panasci, L; Perrault, D; Pritchard, KI; Vandenberg, T1
de Keizer, RJ; Haak, HR; Hagenouw-Taal, JC; van Dulken, H; van Seters, AP; Vielvoye, GJ1

Reviews

1 review(s) available for mifepristone and Local Neoplasm Recurrence

ArticleYear
Laboratory evidence for the hormonal dependency of meningiomas.
    Human reproduction (Oxford, England), 1994, Volume: 9 Suppl 1

    Topics: Combined Modality Therapy; Female; Glucocorticoids; Gonadal Steroid Hormones; Humans; Male; Meningeal Neoplasms; Meningioma; Mifepristone; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Receptors, Steroid; Sex Factors; Steroids

1994

Trials

2 trial(s) available for mifepristone and Local Neoplasm Recurrence

ArticleYear
A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: a gynecologic oncology group study.
    Gynecologic oncology, 2010, Volume: 116, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Disease-Free Survival; Fallopian Tube Neoplasms; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Mifepristone; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms

2010
Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Female; Hormone Antagonists; Humans; Liver Neoplasms; Middle Aged; Mifepristone; Neoplasm Recurrence, Local

1996

Other Studies

4 other study(ies) available for mifepristone and Local Neoplasm Recurrence

ArticleYear
MPA alters metabolic phenotype of endometrial cancer-associated fibroblasts from obese women via IRS2 signaling.
    PloS one, 2022, Volume: 17, Issue:7

    Topics: Acetates; Cancer-Associated Fibroblasts; Endometrial Neoplasms; Female; Glucose; Humans; Insulin Receptor Substrate Proteins; Medroxyprogesterone Acetate; Mifepristone; Neoplasm Recurrence, Local; Obesity; Phenotype; Progesterone; Receptors, Progesterone; RNA, Messenger

2022
Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Nov-15, Volume: 19, Issue:22

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Cell Line, Tumor; Dexamethasone; Drug Resistance, Neoplasm; Dual Specificity Phosphatase 1; Female; Gene Expression; Hormone Antagonists; Humans; Immediate-Early Proteins; Mice; Mice, SCID; Mifepristone; Neoplasm Recurrence, Local; Neoplasm Transplantation; Paclitaxel; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Receptors, Estrogen; Receptors, Glucocorticoid; Signal Transduction; Transplantation, Heterologous; Triple Negative Breast Neoplasms

2013
Mifepristone as treatment of recurrent progesterone receptor-positive uterine leiomyosarcoma.
    Obstetrics and gynecology, 2007, Volume: 109, Issue:2 Pt2

    Topics: Diagnosis, Differential; Female; Hormone Antagonists; Humans; Leiomyosarcoma; Middle Aged; Mifepristone; Neoplasm Recurrence, Local; Neoplasm Staging; Radiography; Receptors, Progesterone; Uterine Neoplasms

2007
Successful mifepristone treatment of recurrent, inoperable meningioma.
    Lancet (London, England), 1990, Jul-14, Volume: 336, Issue:8707

    Topics: Drug Administration Schedule; Drug Evaluation; Female; Humans; Meningeal Neoplasms; Meningioma; Mifepristone; Neoplasm Recurrence, Local

1990